Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.08 is in line with its 5-year average of 1.08, near the low end of its 5-year range (0.42–3.05).
As of the fiscal period ended Tuesday, June 30, 2026. 4.99% above its 12-month average of 1.02.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.08.
QUICK RATIO (ACID-TEST)
1.08
QUICK RATIO (ACID-TEST) AVG TTM
1.02
QUICK RATIO (ACID-TEST) AVG 3Y
0.94
QUICK RATIO (ACID-TEST) AVG 5Y
1.08
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.99%
CURRENT VS 3Y AVG
+13.96%
CURRENT VS 5Y AVG
-0.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-67.89%
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.59M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.02
3Y Avg
0.94
5Y Avg
1.08
Market Cap
$11.53M
Quick Ratio (Acid-Test)
15.87
TTM Avg
27.51
3Y Avg
16.79
5Y Avg
13.69
Market Cap
$11.36M
Quick Ratio (Acid-Test)
5.63
TTM Avg
4.29
3Y Avg
4.04
5Y Avg
3.65
Market Cap
$11.23M
Quick Ratio (Acid-Test)
3.07
TTM Avg
5.09
3Y Avg
9.39
5Y Avg
12.46
Market Cap
$11.12M
Quick Ratio (Acid-Test)
8.97
TTM Avg
5.46
3Y Avg
4.04
5Y Avg
3.77
Market Cap
$11.06M
Quick Ratio (Acid-Test)
3.69
TTM Avg
5.96
3Y Avg
7.84
5Y Avg
10.45
Market Cap
$11.05M
Quick Ratio (Acid-Test)
1.37
TTM Avg
0.79
3Y Avg
1.08
5Y Avg
1.46
Market Cap
$12.19M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.32
3Y Avg
1.15
5Y Avg
1.64
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.59M | 1.08 | 1.02 | 0.94 | 1.08 |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.53M | 15.87 | 27.51 | 16.79 | 13.69 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.36M | 5.63 | 4.29 | 4.04 | 3.65 |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.23M | 3.07 | 5.09 | 9.39 | 12.46 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 8.97 | 5.46 | 4.04 | 3.77 |
| BioVie Inc. (BIVI)vs › | $11.08M | 3.59 | 6.34 | 4.40 | 4.46 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.06M | 3.69 | 5.96 | 7.84 | 10.45 |
| Cerenome, Inc. (CNSY)vs › | $11.05M | 1.37 | 0.79 | 1.08 | 1.46 |
| IRIDEX Corporation (IRIX)vs › | $12.19M | 1.08 | 1.32 | 1.15 | 1.64 |
| Caring Brands, Inc. (CABR)vs › | $10.82M | 4.93 | 13.09 | 13.09 | 13.09 |
Quick Ratio
1.08
Excludes inventory
Current Ratio
1.18
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.08 |
| 2026-03-31 | 1.09 |
| 2025-12-31 | 1.40 |
| 2025-09-30 | 0.80 |
| 2025-06-30 | 0.75 |
| 2025-03-31 | 0.80 |
| 2024-12-31 | 1.17 |
| 2024-09-30 | 0.94 |
| 2024-06-30 | 1.46 |
| 2024-03-31 | 0.94 |
| 2023-12-31 | 0.67 |
| 2023-09-30 | 0.47 |
| 2023-06-30 | 0.69 |
| 2023-03-31 | 1.49 |
| 2022-12-31 | 1.72 |
| 2022-09-30 | 2.12 |
| 2022-06-30 | 2.57 |
| 2022-03-31 | 3.05 |
| 2021-12-31 | 3.03 |
| 2021-09-30 | 0.42 |
| 2021-06-30 | 1.49 |
| 2021-03-31 | 1.90 |
| 2020-12-31 | 2.82 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
